SCOTTI, VIERI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.180
EU - Europa 2.510
AS - Asia 1.923
SA - Sud America 216
Continente sconosciuto - Info sul continente non disponibili 71
AF - Africa 46
OC - Oceania 27
AN - Antartide 1
Totale 8.974
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.082
RU - Federazione Russa 898
IT - Italia 570
SG - Singapore 563
CN - Cina 514
PL - Polonia 285
HK - Hong Kong 271
IE - Irlanda 195
BR - Brasile 168
KR - Corea 166
SE - Svezia 160
VN - Vietnam 146
DE - Germania 104
FR - Francia 98
IN - India 70
FI - Finlandia 69
CA - Canada 62
GB - Regno Unito 61
JO - Giordania 55
AU - Australia 26
BD - Bangladesh 23
ID - Indonesia 19
JP - Giappone 19
TR - Turchia 16
MX - Messico 15
NL - Olanda 15
AR - Argentina 14
IQ - Iraq 11
ZA - Sudafrica 11
ES - Italia 10
CI - Costa d'Avorio 9
UA - Ucraina 7
BG - Bulgaria 6
CO - Colombia 6
EC - Ecuador 6
PK - Pakistan 6
UY - Uruguay 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
BE - Belgio 5
CZ - Repubblica Ceca 5
DO - Repubblica Dominicana 5
EG - Egitto 5
KE - Kenya 5
LT - Lituania 5
NG - Nigeria 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
PE - Perù 4
AT - Austria 3
CH - Svizzera 3
CR - Costa Rica 3
DZ - Algeria 3
HN - Honduras 3
HU - Ungheria 3
JM - Giamaica 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LB - Libano 3
MA - Marocco 3
TH - Thailandia 3
TW - Taiwan 3
AL - Albania 2
BJ - Benin 2
CL - Cile 2
GE - Georgia 2
GR - Grecia 2
IL - Israele 2
MN - Mongolia 2
NP - Nepal 2
PS - Palestinian Territory 2
PY - Paraguay 2
RO - Romania 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
AQ - Antartide 1
BO - Bolivia 1
BY - Bielorussia 1
EU - Europa 1
GT - Guatemala 1
GY - Guiana 1
KY - Cayman, isole 1
LA - Repubblica Popolare Democratica del Laos 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PR - Porto Rico 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
TN - Tunisia 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.905
Salva come PNG Salva come JPEG
Città #
Santa Clara 715
Ashburn 522
Singapore 393
Fairfield 364
Warsaw 280
Hong Kong 240
Dublin 195
Chandler 184
San Jose 166
Seoul 166
Woodbridge 158
Seattle 144
Cambridge 131
Hefei 126
Wilmington 126
Houston 125
Beijing 113
Milan 110
Los Angeles 80
Florence 73
Altamura 65
Lawrence 65
Buffalo 61
Council Bluffs 60
Munich 55
Rome 52
Ho Chi Minh City 50
New York 46
Princeton 45
Paris 44
Hanoi 41
Moscow 41
Ann Arbor 38
Lauterbourg 37
The Dalles 34
Kent 33
Boston 31
Helsinki 28
Mumbai 27
Medford 24
Melbourne 24
Shanghai 22
Dallas 19
San Diego 19
Boardman 18
London 17
São Paulo 16
Tokyo 15
Montreal 14
Naples 14
Bengaluru 13
Falls Church 13
Guangzhou 13
Redondo Beach 13
Clifton 12
Frankfurt am Main 12
Jacksonville 12
Jakarta 11
Orem 11
Phoenix 11
Stockholm 11
Turku 11
Chicago 10
Toronto 10
Turin 10
Abidjan 9
Manchester 9
Bari 8
Bologna 8
Figino 8
San Francisco 8
Atlanta 7
Baghdad 7
Poplar 7
Pune 7
Chennai 6
Dearborn 6
Haiphong 6
Hillsboro 6
Izmir 6
Johannesburg 6
Montevideo 6
Sofia 6
Venice 6
Belo Horizonte 5
Brasília 5
Brooklyn 5
Brussels 5
Catania 5
Des Moines 5
Genoa 5
Modena 5
Abuja 4
Ankara 4
Barcelona 4
Barnet 4
Campinas 4
Denver 4
Dong Ket 4
Fortaleza 4
Totale 5.843
Salva come PNG Salva come JPEG
Nome #
Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study 402
Postmastectomy radiotherapy for locally advanced breast cancer receiving neoadjuvant chemotherapy. 297
Multiple cutaneous angiosarcomas after breast conserving surgery and bilateral adjuvant radiotherapy: an unusual case and review of the literature. 273
Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial 267
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833) 240
Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial 238
Aprepitant as prophylaxis of chemotherapy-induced nausea and vomiting in anthracyclines and cyclophosphamide-based regimen for adjuvant breast cancer 224
Cardioprotective Strategy for Patients with Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical Trial 223
Accelerated partial breast irradiation using intensity-modulated radiotherapy technique compared to whole breast irradiation for patients aged 70 years or older: subgroup analysis from a randomized phase 3 trial 219
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer 212
External accelerated partial breast irradiation for ductal carcinoma in situ: long-term follow-up from a phase 3 randomized trial 208
Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial 208
Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial 208
Ribociclib plus letrozole and concomitant palliative radiotherapy for metastatic breast cancer 201
Accelerated Partial Breast Irradiation with IMRT: New Technical Approach and Interim Analysis of Acute Toxicity in a Phase III Randomized Clinical Trial. 201
91P * DEFINITIVE CONCOMITANT RADIOCHEMOTHERAPY (RCT) TREATMENT FOR LOCALLY ADVANCED (LA) NON SMALL CELL LUNG CANCER (NSCLC): EVALUATION OF HEMATOLOGICAL AND ESOPHAGEAL TOXICITY IN THE RADIATION ONCOLOGY DEPARTMENT OF UNIVERSITY OF FLORENCE EXPERIENCE 201
Application of helical tomotherapy for the treatment of a right atrium angiosarcoma: A case report 199
Predictive factors for additional non-sentinel lymph node involvement in breast cancer patients with one positive sentinel node 195
Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility 194
Adjuvant trastuzumab in breast cancer: experience from the University of Florence. 191
Doxorubicin and cyclophosphamideversus cyclophosphamide, methotrexate, and 5-fluorouracil as adjuvantchemotherapy in breast cancer. 190
Impact of COVID-19 on workload burden of a complex radiotherapy facility 184
Pembrolizumab for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: Analysis of Prognostic Factors of Outcomes 183
76P THE IMPACT OF A BREATHING-CONTROL SYSTEM ON TARGET MARGINS AND NORMAL TISSUE SPARING IN THE TREATMENT OF LUNG CANCER: ANALYSIS OF 12 CASES AT RADIOTHERAPY UNIT OF FLORENCE UNIVERSITY 183
Safety of eribulin mesylate and concomitant radiotherapy for metastatic breast cancer: a single-center experience 183
Quitting Smoking At or Around Diagnosis Improves the Overall Survival of Lung Cancer Patients: A Systematic Review and Meta-Analysis 177
The impact of young age on breast cancer outcome 174
Impact of age on cytotoxic-induced ovarian failure in breast cancer treated with adjuvant chemotherapy and triptorelin 174
Isolated chest wall implantation of non-small cell lung cancer after fine-needle aspiration: a case report and review of the literature. 173
Lobectomy vs Stereotactic Ablative Radiotherapy in NSCLC: a multicentric series in four centers 169
Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO 169
The impact of patient preference in the treatment algorithm for recurrent/metastatic head and neck squamous cell carcinoma 168
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy 168
Prognostic role of human epidermal growth factor receptor 2 status in premenopausal early breast cancer treated with adjuvant tamoxifen. 162
Neoadjuvant oxaliplatin and 5-fluorouracil with concurrent radiotherapy in patients with locally advanced rectal cancer: a singleinstitution experience. 156
Impact of a breathing-control system on target margins and normal-tissue sparing in the treatment of lung cancer: experience at the radiotherapy unit of Florence University. 155
Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression 154
Update chemotherapy schedule in the treatment of lung cancer 150
Correction to: Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility (Supportive Care in Cancer, (2021), 29, 6, (2931-2937), 10.1007/s00520-020-05793-3) 143
Impact of sentinel node tumor burden on outcome of invasive breast cancer patients. 141
Post-operative radiotherapy in N2 non-small cell lung cancer: a retrospective analysis of 175 patients. 137
Recent Advances and Current Challenges in Stereotactic Body Radiotherapy for Ultra-Central Lung Tumors 134
Vinorelbine-based chemo-radiotherapy in non-small cell lung cancer. 126
Radiotherapy timing in the treatment of limited-stage small cell lung cancer: the impact of thoracic and brain irradiation on survival. 126
Is there a worthwhile value in personalizing radiation therapy for breast cancer patients? Time for a new paradigm in the older adult population 121
Postoperative radiotherapyin stage I/II endometrial cancer: retrospective analysis of 883 patients treated at the University of Florence. 111
Circulating Tumor Cell-Free DNA as Prognostic Biomarker in Non-Small Cell Lung Cancer Patients Undergoing Immunotherapy: The CORELAB Experience 106
The role of postoperative radiotherapy for thymomas: a multicentric retrospective evaluation from three Italian centers and review of the literature 101
Desensitization Protocol for Cemiplimab-Related Infusion Reaction in Cutaneous Squamous Cell Carcinoma: A Case Report and Literature Review 35
Retrospective evaluation of the "neutrophil-lymphocyte ratio" (NLR) in patients affected by locally advanced unresectable stage III NSCLC treated with Durvalumab within the Italian expanded access program (EAP): results of the neutrality trial 20
Totale 8.974
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.698
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.698
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022300 0 15 20 15 17 20 11 17 18 12 58 97
2022/2023839 67 199 34 37 59 149 103 49 109 5 15 13
2023/2024422 12 32 46 14 24 70 24 107 6 28 44 15
2024/20252.402 76 225 146 400 643 251 50 160 131 94 98 128
2025/20262.956 352 392 269 216 337 105 339 135 195 196 89 331
2026/2027358 128 230 0 0 0 0 0 0 0 0 0 0
Totale 8.974